sellWeak10b5-1 plan
Stephen K. Brannan sold $1.6M of KRTX
Chief Medical Officer at Karuna Therapeutics, Inc.. 5,000 shares at an average of $316.13, traded Feb 8, 2024, filed Feb 12, 2024.
Warning score
10Value
$1.6M
5,000 shares
Holdings after
41,150
-11% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +25Trade size$1.6M at market
- +5Share of holdings soldSold 11% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-013959, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 8, 2024 | MOption exercise Common Stock10b5-1 | +2,500 | $5.45 | $14k | 41,150 | Feb 12, 2024 |
| Feb 8, 2024 | MOption exercise Common Stock10b5-1 | +5,000 | $111.97 | $560k | 46,150 | Feb 12, 2024 |
| Feb 8, 2024 | SOpen-market sale Common Stock10b5-1 | -4,182 | $316.05 | $1.3M | 41,968 | Feb 12, 2024 |
| Feb 8, 2024 | SOpen-market sale Common Stock10b5-1 | -818 | $316.56 | $259k | 41,150 | Feb 12, 2024 |
| Feb 9, 2024 | FTax withholding Common Stock10b5-1 | -1,046 | $317.14 | $332k | 40,104 | Feb 12, 2024 |
| Feb 8, 2024 | MOption exercise Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 7,177 | Feb 12, 2024 |
| Feb 8, 2024 | MOption exercise Option (right to buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 39,604 | Feb 12, 2024 |
Related signals
Other insiders at Karuna Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.6M 5,000 shares | -11% | |
| 15Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $4.8M 15,000 shares | -28% | |
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $2.0M 10,000 shares | -22% | |
| 8Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $889k 5,000 shares | -13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.